+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 160 Pages
  • Global
From
Transdermal Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Transdermal Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032 - Product Thumbnail Image

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

  • Report
  • February 2022
  • 421 Pages
  • Global
From
Inhalation Anesthesia Market Report 2025 - Product Thumbnail Image

Inhalation Anesthesia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 383 Pages
  • Global
From
Crohn Disease Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Crohn Disease Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 81 Pages
  • Global
From
Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • March 2024
  • 250 Pages
  • Global
From
Skin Rash Treatment - Global Strategic Business Report - Product Thumbnail Image

Skin Rash Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 384 Pages
  • Global
From
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) and Region - Forecast to 2028 - Product Thumbnail Image

Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) and Region - Forecast to 2028

  • Report
  • December 2023
  • 307 Pages
  • Global
From
Drug Manufacturing Sector Scorecard - Thematic Intelligence - Product Thumbnail Image

Drug Manufacturing Sector Scorecard - Thematic Intelligence

  • Report
  • October 2022
  • 23 Pages
  • Global
From
Antithrombotic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antithrombotic Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 282 Pages
  • Global
From
Gastrointestinal Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 193 Pages
  • Global
From
Glutamate Receptor Ionotropic NMDA 2B Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Glutamate Receptor Ionotropic NMDA 2B Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • May 2022
  • 95 Pages
  • Global
From
Diverticulitis Disease - Global Strategic Business Report - Product Thumbnail Image

Diverticulitis Disease - Global Strategic Business Report

  • Report
  • June 2025
  • 294 Pages
  • Global
From
Psoriatic Arthritis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 452 Pages
  • Global
From
IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By Country: Market Insights and Forecast (2024-2030) - Product Thumbnail Image

IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By Country: Market Insights and Forecast (2024-2030)

  • Report
  • November 2023
  • 170 Pages
  • Global
From
Ankylosing Spondylitis - Global Strategic Business Report - Product Thumbnail Image

Ankylosing Spondylitis - Global Strategic Business Report

  • Report
  • June 2025
  • 271 Pages
  • Global
From
Idiopathic Thrombocytopenic Purpura Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 277 Pages
  • Global
From
Interstitial Cystitis - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Cystitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator